To confirm our findings in the human system, we used the human lung cancer cell line HCC827 with exon 19 deletion in EGFR, which is an activating mutation that results in excess EGFR expression (Lee et al, 2018; Robichaux et al, 2021). This evidence concerns the gene EGFR and lung cancer.